Implantation of a trabecular micro-bypass stent in patients with all types of glaucoma and moderate to severe glaucoma damage showed long-term efficacy and safety in a real-world, prospective, nonrandomized study at the University of Heidelberg, Germany.
Patients were divided into two cohorts and received the iStent inject (Glaukos) in combination with cataract surgery or as a stand-alone procedure.
“We included nearly all patients referred for surgery to our hospital if they were anatomically suitable to undergo this type of implant. We had patients with primary open-angle glaucoma,
Uncategorized